AstraZeneca to Expand Zibotentan-Dapa Global Trial

AstraZeneca has received a green signal from the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) for a protocol being amended to widen the ongoing global clinical trial

Roche, 10 Govt Hospitals Partner to Boost Clinical Trials

Roche Pharma India today announced the successful completion of the first phase of its Advanced Inclusive Research (AIR) Site Alliance initiative in India, having partnered with 10 leading government hospitals from across the country and trained...

Sun Pharma Secures Interim Court Order on URSOCOL

The Bombay High Court has given an interim injunction to Sun Pharma Laboratories Limited, which will stop Rambo Lifesciences Pvt. Ltd.

AiMeD Hails Govt's Move on New GST Regime Transition

The Association of Indian Medical Device Industry (AiMeD) has expressed its whole-hearted support for the latest instructions issued by the Department of Pharmaceuticals (DoP), National Pharmaceutical Pricing Authority

Apollo Hospitals to Full Takeover of Apollo Health & Lifestyle

The healthcare chain Apollo Hospitals Entreprise Ltd said that it will pay Rs 1,254.07 crore to purchase the 31% share that International Finance Corporation had in its subsidiary Apollo Health and Lifestyle Ltd.

New GST Regime Lowers Cost of Drugs, Devices

The new GST regime, the government has instructed pharmaceutical companies to rework the maximum retail price (MRP) of drugs, formulations, and medical devices from September 22, 2025.

Cotec Healthcare IPO Launches with DRHP Filing

Cotec Healthcare, one of the most successful contract development and manufacturing organizations (CDMO), in India has petitioned its Draft Red Herring Prospectus with an intention to raise up to 750 crores of funds by way of Fresh Issue plus an...

Natco Pharma Issues Statement on Adcock Ingram Buy

Natco Pharma Limited, a wholly owned subsidiary in South Africa, conjointly with Adcock Ingram Holdings Limited, has circulated a joint circular to the Adcock Ingram’s shareholders.

Merck's Capvaxive Shows Strong Phase 3 Results in Kids

Merck (known as MSD outside of the US and Canada) presented positive Phase 3 trial results for Capvaxive for kids at the 6th ESCMID Conference on Vaccines in Lisbon, Portugal. The STRIDE-13 study assessed the vaccine in children and adolescents...

USFDA Acts Against Misleading Pharma Advertising

The U.S. Food and Drug Administration (FDA), with the support of the Department of Health and Human Services (HHS), has revealed strict measures, With the aim to shield consumers in a major way

on the deck


Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.